Assessment of Erlotinib as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer Patients

Academic Article

Abstract

  • Purpose: To determine the tolerability and efficacy of long-term treatment with erlotinib for head and neck squamous cell carcinoma after salvage surgery.

    • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Rosenthal EL; Chung TK; Carroll WR; Clemons L; Desmond R; Nabell L

    • Start Page

  • 4263

    • End Page

  • 4269

    • Volume

  • 21

    • Issue

  • 13